1-8 of 8
Anthony R. Mato
Close
Sort by
Journal Articles

Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry

Clinical Trials & Observations
Anthony R. Mato, Nilanjan Ghosh, Jeff P. Sharman, Danielle Brander, Meghan Gutierrez, Qing Huang, Linda H. Wu, Alex Young, Sandhya Upasani, Maoko Naganuma, Jacqueline C. Barrientos
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4760–4764.
https://doi.org/10.1182/bloodadvances.2022008068
Published: 2023
Includes: Supplemental data
Journal Articles

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia

Lindsey E. Roeker, Maral DerSarkissian, Kellie Ryan, Yan Chen, Mei Sheng Duh, Svea K. Wahlstrom, Shweta Hakre, Louise Yu, Helen Guo, Anthony R. Mato
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4291–4301.
https://doi.org/10.1182/bloodadvances.2023009739
Published: 2023
Includes: Supplemental data
Journal Articles

Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia

Clinical Trials & Observations
Saar Gill, Vanessa Vides, Noelle V. Frey, Elizabeth O. Hexner, Susan Metzger, Megan O'Brien, Wei-Ting Hwang, Jennifer L. Brogdon, Megan M. Davis, Joseph A. Fraietta, Avery L. Gaymon, Whitney L. Gladney, Simon F. Lacey, Anne Lamontagne, Anthony R. Mato, Marcela V. Maus, J. Joseph Melenhorst, Edward Pequignot, Marco Ruella, Maksim Shestov, John C. Byrd, Stephen J. Schuster, Donald L. Siegel, Bruce L. Levine, Carl H. June, David L. Porter
Journal: Blood Advances
Blood Adv (2022) 6 (21): 5774–5785.
https://doi.org/10.1182/bloodadvances.2022007317
Published: 2022
Includes: Supplemental data
Journal Articles

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

Clinical Trials & Observations
Meghan C. Thompson, Rosemary A. Harrup, Catherine C. Coombs, Lindsey E. Roeker, Jeffrey J. Pu, Michael Y. Choi, Paul M. Barr, John N. Allan, Martin Šimkovič, Lori Leslie, Joanna Rhodes, Elise A. Chong, Manali Kamdar, Alan Skarbnik, Frederick Lansigan, Brittany McCall, Khalid Saja, Martin J. S. Dyer, Harriet S. Walter, Marcus Lefebure, Maria Thadani-Mulero, Michelle Boyer, Juliana Biondo, Kavita Sail, Beenish S. Manzoor, Richard Furman, Kurt S. Bantilan, Andre Goy, Tatyana Feldman, Dominic Labella, Stephen J. Schuster, Jae Park, Lia Palomba, Andrew Zelenetz, Toby A. Eyre, Arnon P. Kater, John F. Seymour, Anthony R. Mato
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4553–4557.
https://doi.org/10.1182/bloodadvances.2022007812
Published: 2022
Journal Articles

Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter’s transformation

Clinical Trials & Observations
Oscar B. Lahoud, Sean M. Devlin, Molly A. Maloy, Lindsey E. Roeker, Parastoo B. Dahi, Doris M. Ponce, Boglarka Gyurkocza, Guenther Koehne, James W. Young, Hugo R. Castro-Malaspina, Juliet N. Barker, Esperanza B. Papadopoulos, Ann A. Jakubowski, Andrew D. Zelenetz, Anthony R. Mato, Sergio A. Giralt, Miguel A. Perales, Craig S. Sauter
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2879–2889.
https://doi.org/10.1182/bloodadvances.2020003726
Published: 2021
Journal Articles

Overcoming resistance to targeted therapies in chronic lymphocytic leukemia

Sigrid S. Skånland, Anthony R. Mato
Journal: Blood Advances
Blood Adv (2021) 5 (1): 334–343.
https://doi.org/10.1182/bloodadvances.2020003423
Published: 2021
Journal Articles

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

Lindsey E. Roeker, Peter Dreger, Jennifer R. Brown, Oscar B. Lahoud, Toby A. Eyre, Danielle M. Brander, Alan Skarbnik, Catherine C. Coombs, Haesook T. Kim, Matthew Davids, Steven T. Manchini, Gemlyn George, Nirav Shah, Timothy J. Voorhees, Kim H. Orchard, Harriet S. Walter, Arvind K. Arumainathan, Andrea Sitlinger, Jae H. Park, Mark B. Geyer, Andrew D. Zelenetz, Craig S. Sauter, Sergio A. Giralt, Miguel-Angel Perales, Anthony R. Mato
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3977–3989.
https://doi.org/10.1182/bloodadvances.2020001956
Published: 2020
Journal Articles

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

Clinical Trials & Observations
Anthony R. Mato, Lindsey E. Roeker, Toby A. Eyre, Chadi Nabhan, Nicole Lamanna, Brian T. Hill, Danielle M. Brander, Paul M. Barr, Frederick Lansigan, Bruce D. Cheson, Arun K. Singavi, Maryam Sarraf Yazdy, Nirav N. Shah, John N. Allan, Erica B. Bhavsar, Joanna Rhodes, Kaitlin Kennard, Stephen J. Schuster, AnnaLynn M. Williams, Alan P. Skarbnik, Andre H. Goy, Julie M. Goodfriend, Colleen Dorsey, Catherine C. Coombs, Hande Tuncer, Chaitra S. Ujjani, Ryan Jacobs, Allison M. Winter, John M. Pagel, Neil Bailey, Anna Schuh, Mazyar Shadman, Andrea Sitlinger, Hanna Weissbrot, Sivraj Muralikrishnan, Andrew Zelenetz, Amy A. Kirkwood, Christopher P. Fox
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1568–1573.
https://doi.org/10.1182/bloodadvances.2019000180
Published: 2019